How can China's medical manufacturing listed firms improve their technological innovation efficiency? An analysis based on a three-stage DEA model and corporate governance configurations
Technological Forecasting and Social Change · 2023-09 · 194 · 122684
DOI: 10.1016/j.techfore.2023.122684 ↗Kurz gefasst
Fachartikel in der Zeitschrift Technological Forecasting and Social Change, 2023-09. Verfasst von Liping Qiu und 4 weiteren Autor:innen. Die Arbeit wurde bisher 147-mal zitiert (Crossref) und nennt 136 Literaturangaben. Gefördert von: Humanities and Social Science Fund of Ministry of Education of China, National Natural Science Foundation of China, National Office for Philosophy and Social Sciences.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Förderung
- Humanities and Social Science Fund of Ministry of Education of China
- National Natural Science Foundation of China
- National Office for Philosophy and Social Sciences
Zitieren
APA
Qiu, L., Yu, R., Hu, F., Zhou, H., & Hu, H. (2023). How can China's medical manufacturing listed firms improve their technological innovation efficiency? An analysis based on a three-stage DEA model and corporate governance configurations. Technological Forecasting and Social Change, 194, 122684. https://doi.org/10.1016/j.techfore.2023.122684
Vancouver
Qiu L, Yu R, Hu F, Zhou H, Hu H. How can China's medical manufacturing listed firms improve their technological innovation efficiency? An analysis based on a three-stage DEA model and corporate governance configurations. Technological Forecasting and Social Change. 2023;194:122684. doi:10.1016/j.techfore.2023.122684
BibTeX
@article{Qiu2023,
author = {Qiu, Liping and Yu, Rongjian and Hu, Feng and Zhou, Haiyan and Hu, Hao},
title = {How can China's medical manufacturing listed firms improve their technological innovation efficiency? An analysis based on a three-stage DEA model and corporate governance configurations},
journal = {Technological Forecasting and Social Change},
year = {2023},
volume = {194},
pages = {122684},
doi = {10.1016/j.techfore.2023.122684}
}
EUVIMED